ln229 human glioblastoma cell lines (ATCC)
Structured Review

Ln229 Human Glioblastoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1944 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ln229 human glioblastoma cell lines/product/ATCC
Average 99 stars, based on 1944 article reviews
Images
1) Product Images from "CD38 overexpression drives glioblastoma progression via L1CAM/ICAM1/JAK-STAT-Driven tumor microenvironment rewiring"
Article Title: CD38 overexpression drives glioblastoma progression via L1CAM/ICAM1/JAK-STAT-Driven tumor microenvironment rewiring
Journal: Translational Oncology
doi: 10.1016/j.tranon.2026.102758
Figure Legend Snippet: A. Evaluation of CD38 expression following human and mouse GBM cell lines (A) and (B) overexpression of CD38 in T98G and Ln229 (human GBM cell lines) using western blot and fluorescent microscope imaging. (C) Significant overexpression of CD38 in transduced Gl-261 cells compared to wild type Gl-261 cells. B Kaplan-Meier overall survival analysis indicated significantly decreased in CD38-OE GBM- bearing mice (26.45 days) versus CD38-WT GBM- bearing mice (35.73 days) (p < 0.0001; n = 11 per group).
Techniques Used: Expressing, Over Expression, Western Blot, Microscopy, Imaging
Figure Legend Snippet: A. Comparison of doubling time among CD38-OE, CD38-WT, and CD38-Knockdown human GBM cells (T98G and LN229) and CD38-OE, CD38-WT GL-261 cells displayed non-significant changes. (n = 3, triplicate). One-way ANOVA, no significant differences. B Western blot quantification of CKIs (p16, p21, p27) in GL-261 cells (n = 3). One-way ANOVA, no significant differences.
Techniques Used: Comparison, Knockdown, Western Blot

